VERZENIO
Drug
Lilly USA, LLC
Total Payments
$9.2M
Transactions
48,133
Doctors
9,973
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.3M | 13,974 | 5,612 |
| 2023 | $1.5M | 12,068 | 4,813 |
| 2022 | $1.3M | 6,447 | 2,928 |
| 2021 | $987,423 | 5,014 | 2,223 |
| 2020 | $586,172 | 1,166 | 571 |
| 2019 | $2.2M | 5,866 | 1,491 |
| 2018 | $1.3M | 3,058 | 1,094 |
| 2017 | $10,181 | 540 | 442 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6.9M | 3,893 | 75.9% |
| Consulting Fee | $1.0M | 364 | 11.2% |
| Food and Beverage | $903,728 | 40,859 | 9.9% |
| Travel and Lodging | $204,210 | 2,211 | 2.2% |
| Education | $74,432 | 805 | 0.8% |
| Unspecified | $4,000 | 1 | 0.0% |
Payments by Type
General
$9.2M
48,132 transactions
Research
$4,000
1 transactions
Top Doctors Receiving Payments for VERZENIO — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Medical Oncology | Fort Myers, FL | $120,052 | 101 |
| , MD | Hematology & Oncology | Corona, CA | $111,690 | 111 |
| , MD | Hematology | Providence, RI | $108,444 | 84 |
| , MD, PHD | Internal Medicine | Puyallup, WA | $108,167 | 131 |
| , M.D | Hematology & Oncology | Plantation, FL | $84,468 | 121 |
| , M.D | Medical Oncology | Southaven, MS | $83,493 | 56 |
| , M.D | Hematology & Oncology | Spartanburg, SC | $82,595 | 88 |
| , MD | Hematology | Stamford, CT | $82,222 | 114 |
| , M.D | Internal Medicine | Davie, FL | $80,807 | 93 |
| , MD | Hematology & Oncology | Binghamton, NY | $77,649 | 83 |
| , M.D | Specialist | San Francisco, CA | $67,156 | 72 |
| , MD | Medical Oncology | Austin, TX | $61,554 | 72 |
| , MD | Hospitalist | Louisville, KY | $61,052 | 64 |
| , M.D | Medical Oncology | Kansas City, KS | $59,854 | 39 |
| , M.D | Hematology & Oncology | Annapolis, MD | $57,293 | 38 |
| , MSN, NP | Hematology & Oncology | Santa Monica, CA | $55,027 | 95 |
| , MD | Medical Oncology | Philadelphia, PA | $53,571 | 37 |
| , MD | Hematology & Oncology | Miami Beach, FL | $53,483 | 91 |
| , MD | Medical Oncology | Dallas, TX | $47,304 | 41 |
| , M.D | Hematology & Oncology | Voorhees, NJ | $46,062 | 50 |
| , MD | Hematology & Oncology | Baltimore, MD | $43,872 | 65 |
| , MD | Hematology & Oncology | Griffin, GA | $39,617 | 52 |
| , MD | Medical Oncology | Tampa, FL | $38,354 | 32 |
| , MD | Internal Medicine | San Juan, PR | $36,093 | 64 |
| , M.D | Hematology | Santa Monica, CA | $35,419 | 31 |
Ad
Manufacturing Companies
- Lilly USA, LLC $8.9M
- Eli Lilly and Company $162,153
- Eli Lilly Export S.A. Puerto Rico Branch $107,889
Product Information
- Type Drug
- Total Payments $9.2M
- Total Doctors 9,973
- Transactions 48,133
About VERZENIO
VERZENIO is a drug associated with $9.2M in payments to 9,973 healthcare providers, recorded across 48,133 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.
Payment data is available from 2017 to 2024. In 2024, $1.3M was paid across 13,974 transactions to 5,612 doctors.
The most common payment nature for VERZENIO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6.9M, 75.9% of total).